JNJ

230.16

+0.93%↑

UNH

371.5

+0.84%↑

TMO

476.61

+2.17%↑

ISRG

455.46

+0.87%↑

ABT

90.47

-1.62%↓

JNJ

230.16

+0.93%↑

UNH

371.5

+0.84%↑

TMO

476.61

+2.17%↑

ISRG

455.46

+0.87%↑

ABT

90.47

-1.62%↓

JNJ

230.16

+0.93%↑

UNH

371.5

+0.84%↑

TMO

476.61

+2.17%↑

ISRG

455.46

+0.87%↑

ABT

90.47

-1.62%↓

JNJ

230.16

+0.93%↑

UNH

371.5

+0.84%↑

TMO

476.61

+2.17%↑

ISRG

455.46

+0.87%↑

ABT

90.47

-1.62%↓

JNJ

230.16

+0.93%↑

UNH

371.5

+0.84%↑

TMO

476.61

+2.17%↑

ISRG

455.46

+0.87%↑

ABT

90.47

-1.62%↓

Search

Treace Medical Concepts Inc

Abierto

1.81 2.84

Resumen

Variación precio

24h

Actual

Mínimo

1.71

Máximo

1.8199999999999998

Métricas clave

By Trading Economics

Ingresos

6.9M

-9.4M

Ventas

12M

63M

Margen de beneficios

-15.026

Empleados

450

EBITDA

7M

-5.2M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+113.61% upside

Dividendos

By Dow Jones

Próximas Ganancias

8 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-3.7M

124M

Apertura anterior

-1.03

Cierre anterior

1.81

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Treace Medical Concepts Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

29 abr 2026, 23:53 UTC

Ganancias

Naver Posts Weaker First-Quarter Earnings

29 abr 2026, 23:41 UTC

Acciones populares

Stocks to Watch: Meta Platforms, Alphabet, Qualcomm, Amazon.com

29 abr 2026, 23:55 UTC

Ganancias

Samsung Electronics 1Q Net Profit Beat FactSet-Compiled Consensus

29 abr 2026, 23:54 UTC

Ganancias

Samsung Electronics 1Q Net KRW47.225T Vs. Net KRW8.223T >005930.SE

29 abr 2026, 23:52 UTC

Ganancias

Samsung Electronics 1Q Oper Pft KRW57.233T Vs. Pft KRW6.685T >005930.SE

29 abr 2026, 23:51 UTC

Ganancias

Samsung Electronics 1Q Rev KRW133.873T Vs. KRW79.141T >005930.SE

29 abr 2026, 23:51 UTC

Charlas de Mercado

Nikkei May Fall Amid Uncertainty Over Mideast Conflict -- Market Talk

29 abr 2026, 23:34 UTC

Charlas de Mercado

Gold Edges Higher on Likely Technical Recovery -- Market Talk

29 abr 2026, 23:24 UTC

Ganancias

CSC Financial 1Q Results Supported By Higher Income From Fees, Commission>6066.HK

29 abr 2026, 23:24 UTC

Ganancias

CSC Financial Gains From Changes in Fair Value on Financial Assets Also Aided Results>6066.HK

29 abr 2026, 23:24 UTC

Ganancias

CSC Financial 1Q Net CNY3.67B Vs. Net CNY1.84B >6066.HK

29 abr 2026, 23:24 UTC

Ganancias

CSC Financial 1Q Rev CNY7.70B Vs. CNY4.74B >6066.HK

29 abr 2026, 23:22 UTC

Ganancias

China Longyuan 1Q Net CNY1.70B, Down 14%

29 abr 2026, 23:22 UTC

Ganancias

China Longyuan: Power Generation Down 2.9% as of End-March

29 abr 2026, 23:20 UTC

Ganancias

China Longyuan: 1Q Rev From Wind Power Fell, Rev From Solar Power Rose

29 abr 2026, 23:20 UTC

Ganancias

China Longyuan 1Q Rev CNY7.87B, Down 3.6%

29 abr 2026, 23:19 UTC

Ganancias

China Vanke 1Q Loss CNY5.95B Vs. Loss CNY6.25B >000002.SZ

29 abr 2026, 23:19 UTC

Ganancias

China Vanke: Weak China Real Estate Market Continue to Weigh on Results>000002.SZ

29 abr 2026, 23:19 UTC

Ganancias

China Vanke 1Q Rev CNY28.93B Vs. CNY37.99B >000002.SZ

29 abr 2026, 23:19 UTC

Ganancias

China Vanke 1Q Loss Narrows>000002.SZ

29 abr 2026, 23:18 UTC

Ganancias

Naver1Q Net Profit Missed FactSet-Compiled Consensus

29 abr 2026, 23:17 UTC

Ganancias

Naver 1Q Net KRW291.00B Vs. Net KRW423.70B >035420.SE

29 abr 2026, 23:15 UTC

Ganancias

Naver 1Q Oper Pft KRW541.80B Vs. Pft KRW505.30B >035420.SE

29 abr 2026, 23:15 UTC

Ganancias

Naver 1Q Rev KRW3.241T Vs. KRW2.787T >035420.SE

29 abr 2026, 23:13 UTC

Ganancias

CICC: Gains From Investments in Financial Instruments Also Aided Results >3908.HK

29 abr 2026, 23:12 UTC

Ganancias

CICC Results Supported by Increase in Fee, Commission Income >3908.HK

29 abr 2026, 23:11 UTC

Ganancias

CICC 1Q Rev CNY8.83B Vs. CNY5.72B >3908.HK

29 abr 2026, 23:11 UTC

Ganancias

CICC 1Q Net CNY3.58B Vs. Net CNY2.04B >3908.HK

29 abr 2026, 23:04 UTC

Ganancias

Microsoft Reports Strong Cloud Growth, but Questions About AI Returns Persist -- WSJ

29 abr 2026, 23:04 UTC

Ganancias

Meta Reports Big Revenue Jump and Projected Spending Increase -- 3rd Update

Comparación entre iguales

Cambio de precio

Treace Medical Concepts Inc previsión

Precio Objetivo

By TipRanks

113.61% repunte

Estimación a 12 Meses

Media 4.08 USD  113.61%

Máximo 7 USD

Mínimo 2.25 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Treace Medical Concepts Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

4 ratings

1

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

7.16 / 7.65Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bullish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
help-icon Live chat